IGC Pharma Inc (IGC)
0.447
+0.02
(+3.95%)
USD |
NYAM |
Apr 26, 16:00
0.48
+0.03
(+7.38%)
After-Hours: 20:00
IGC Pharma Free Cash Flow: -6.55M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.55M |
| September 30, 2023 | -6.913M |
| June 30, 2023 | -6.828M |
| March 31, 2023 | -7.666M |
| December 31, 2022 | -7.448M |
| September 30, 2022 | -7.882M |
| June 30, 2022 | -8.641M |
| March 31, 2022 | -8.233M |
| December 31, 2021 | -9.388M |
| September 30, 2021 | -8.958M |
| June 30, 2021 | -9.38M |
| March 31, 2021 | -12.39M |
| December 31, 2020 | -12.48M |
| September 30, 2020 | -14.35M |
| June 30, 2020 | -14.05M |
| March 31, 2020 | -13.14M |
| December 31, 2019 | -11.59M |
| September 30, 2019 | -9.039M |
| June 30, 2019 | -6.896M |
| March 31, 2019 | -3.39M |
| December 31, 2018 | -3.093M |
| September 30, 2018 | -2.226M |
| June 30, 2018 | -2.149M |
| March 31, 2018 | -2.132M |
| December 31, 2017 | -2.195M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.628M |
| June 30, 2017 | -2.262M |
| March 31, 2017 | -1.537M |
| December 31, 2016 | -0.8947M |
| September 30, 2016 | -0.9676M |
| June 30, 2016 | 0.4689M |
| March 31, 2016 | -0.2799M |
| December 31, 2015 | 0.3528M |
| September 30, 2015 | 0.1679M |
| June 30, 2015 | -2.350M |
| March 31, 2015 | -2.660M |
| December 31, 2014 | -3.885M |
| September 30, 2014 | -4.148M |
| June 30, 2014 | -2.358M |
| March 31, 2014 | -1.742M |
| December 31, 2013 | -1.562M |
| September 30, 2013 | 0.3846M |
| June 30, 2013 | 0.4018M |
| March 31, 2013 | 0.5648M |
| December 31, 2012 | -2.567M |
| September 30, 2012 | -4.449M |
| June 30, 2012 | -4.683M |
| March 31, 2012 | -5.028M |
| December 31, 2011 | -1.630M |
| September 30, 2011 | -1.638M |
Free Cash Flow Range, Past 5 Years
-14.35M
Minimum
Sep 2020
-6.55M
Maximum
Dec 2023
-9.570M
Average
-8.958M
Median
Sep 2021
Free Cash Flow Benchmarks
| CEL-SCI Corp | -23.45M |
| AIM ImmunoTech Inc | -21.85M |
| NovaBay Pharmaceuticals Inc | -4.15M |
| Protalix BioTherapeutics Inc | -2.467M |
| Palatin Technologies Inc | -26.75M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.587M |
| Cash from Investing (Quarterly) | -0.061M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow Per Share (Quarterly) | -0.0263 |
| Free Cash Flow to Equity (Quarterly) | -1.673M |
| Free Cash Flow to Firm (Quarterly) | -1.674M |
| Free Cash Flow Yield | -26.15% |